Vident Investment Advisory’s Guardant Health GH Stock Holding History

Vident Investment Advisory’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-9,010	Closed	-$1.12M	–	1188
2021 Q2	$1.12M	Buy	9,010 +1,051	+13%	+$141K	0.03%	630
2021 Q1	$1.22M	Buy	7,959 +2,879	+57%	+$435K	0.04%	562
2020 Q4	$655K	Buy	5,080 +3,057	+151%	+$352K	0.03%	646
2020 Q3	$226K	Buy	+2,023	New	+$185K	0.01%	814

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Vident Investment Advisory's GH Position: Q3 2021 in Review

Vident Investment Advisory sold out of Guardant Health (GH) in Q3 2021, closing a stake of 9,010 shares — an estimated $1.12M sold.

Vident Investment Advisory first reported a position in GH in Q3 2020 and held it in 4 quarters. The position peaked at $1.22M in Q1 2021. 374 funds tracked by Wall St. Rank hold GH as of Q3 2021.

Vident Investment Advisory reported no remaining Guardant Health position as of Q3 2021 after selling out during the quarter.
Vident Investment Advisory sold 9,010 Guardant Health shares in Q3 2021, an estimated $1.12M.
Vident Investment Advisory first reported a position in Guardant Health in Q3 2020 and held it in 4 quarters.
Vident Investment Advisory's Guardant Health position peaked at $1.22M in Q1 2021.
374 funds tracked by Wall St. Rank held Guardant Health as of Q3 2021.

Based on Vident Investment Advisory's 13F filing for Q3 2021, filed 12 Nov 2021.